• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Breakthrough COVID-19 Infections After mRNA Vaccination in Solid Organ Transplant Recipients in Miami, Florida.

作者信息

Anjan Shweta, Natori Yoichiro, Fernandez Betances Anmary A, Agritelley Matthew S, Mattiazzi Adela, Arosemena Leopoldo, Andrews David M, Simkins Jacques, Guerra Giselle, Abbo Lilian M

机构信息

Department of Medicine, Division of Infectious Disease, University of Miami Miller School of Medicine Miami, FL.

Miami Transplant Institute, Miami, FL.

出版信息

Transplantation. 2021 Oct 1;105(10):e139-e141. doi: 10.1097/TP.0000000000003902.

DOI:10.1097/TP.0000000000003902
PMID:34319928
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8487698/
Abstract
摘要

相似文献

1
Breakthrough COVID-19 Infections After mRNA Vaccination in Solid Organ Transplant Recipients in Miami, Florida.佛罗里达州迈阿密实体器官移植受者接种mRNA疫苗后出现的突破性新冠病毒感染情况。
Transplantation. 2021 Oct 1;105(10):e139-e141. doi: 10.1097/TP.0000000000003902.
2
Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）信使核糖核酸（mRNA）疫苗接种的实体器官移植受者的抗体动力学和持久性
Transplantation. 2021 Oct 1;105(10):e137-e138. doi: 10.1097/TP.0000000000003863.
3
SARS-CoV-2 Vaccination and Solid Organ Transplant Patients: Data Needed to Inform Safety and Efficacy.严重急性呼吸综合征冠状病毒2型疫苗接种与实体器官移植患者：为安全性和有效性提供信息所需的数据
Transplantation. 2021 Oct 1;105(10):e131-e132. doi: 10.1097/TP.0000000000003747.
4
Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series.实体器官移植受者接种第三剂新冠病毒疫苗的安全性和免疫原性：病例系列
Ann Intern Med. 2021 Sep;174(9):1330-1332. doi: 10.7326/L21-0282. Epub 2021 Jun 15.
5
Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).肾移植受者对 BNT162b2（辉瑞-生物科技）接种 SARS-CoV-2 疫苗的体液免疫反应受损。
Viruses. 2021 Apr 25;13(5):756. doi: 10.3390/v13050756.
6
Safety and Immunogenicity of Anti-SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants.实体器官移植受者中抗SARS-CoV-2信使核糖核酸疫苗的安全性和免疫原性
Ann Intern Med. 2021 Sep;174(9):1336-1338. doi: 10.7326/M21-1341. Epub 2021 May 25.
7
Poor Humoral Response in Solid Organ Transplant Recipients Following Complete mRNA SARS-CoV-2 Vaccination.实体器官移植受者完成mRNA SARS-CoV-2疫苗接种后体液免疫反应不佳。
Clin Chem. 2021 Dec 30;68(1):251-253. doi: 10.1093/clinchem/hvab149.
8
Risk of Breakthrough SARS-CoV-2 Infections in Adult Transplant Recipients.成年移植受者中出现SARS-CoV-2突破性感染的风险。
Transplantation. 2021 Nov 1;105(11):e265-e266. doi: 10.1097/TP.0000000000003907.
9
COVID-19 vaccination in our transplant recipients: The time is now.新冠病毒疫苗在我们移植受者中的应用：现在是时候了。
J Heart Lung Transplant. 2021 Mar;40(3):169-171. doi: 10.1016/j.healun.2020.12.009. Epub 2021 Jan 2.
10
Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.立陶宛血液系统恶性肿瘤患者的 BNT162b2 COVID-19 mRNA 疫苗免疫原性和早期临床结局：一项全国前瞻性队列研究。
Lancet Haematol. 2021 Aug;8(8):e583-e592. doi: 10.1016/S2352-3026(21)00169-1. Epub 2021 Jul 2.

引用本文的文献

1
Long-Term Immuno-Response and Risk of Breakthrough Infection After SARS-CoV-2 Vaccination in Kidney Transplantation.肾移植受者接种 SARS-CoV-2 疫苗后的长期免疫反应及突破性感染风险
Vaccines (Basel). 2025 May 26;13(6):566. doi: 10.3390/vaccines13060566.
2
Clinical outcomes in immunocompromised adults with COVID-19, based on anti-spike IgG serostatus and monoclonal antibody therapy: a retrospective cohort study in the Omicron period.基于抗刺突IgG血清状态和单克隆抗体治疗的免疫功能低下成人COVID-19临床结局：奥密克戎时期的一项回顾性队列研究
Ther Adv Infect Dis. 2025 Feb 17;12:20499361251320711. doi: 10.1177/20499361251320711. eCollection 2025 Jan-Dec.
3
Vaccination for solid organ transplanted patients: Recommendations, efficacy, and safety.实体器官移植患者的疫苗接种：建议、疗效与安全性
World J Transplant. 2024 Dec 18;14(4):92172. doi: 10.5500/wjt.v14.i4.92172.
4
Role of SARS-CoV-2-specific memory B cells promoting immune protection after booster vaccination in solid organ transplantation.SARS-CoV-2 特异性记忆 B 细胞在增强免疫后促进实体器官移植免疫保护的作用。
Front Immunol. 2024 Oct 8;15:1463769. doi: 10.3389/fimmu.2024.1463769. eCollection 2024.
5
COVID-19 vaccine updates for people under different conditions.不同人群的 COVID-19 疫苗更新信息。
Sci China Life Sci. 2024 Nov;67(11):2323-2343. doi: 10.1007/s11427-024-2643-1. Epub 2024 Jul 29.
6
Hybrid Immunity Overcomes Defective Immune Response to COVID-19 Vaccination in Kidney Transplant Recipients.混合免疫克服了肾移植受者对COVID-19疫苗接种的免疫反应缺陷。
Kidney Int Rep. 2023 Dec 20;9(3):635-648. doi: 10.1016/j.ekir.2023.12.008. eCollection 2024 Mar.
7
A Pilot Single-Blinded, Randomized, Controlled Trial Comparing BNT162b2 vs. JNJ-78436735 Vaccine as the Third Dose After Two Doses of BNT162b2 Vaccine in Solid Organ Transplant Recipients.一项比较 BNT162b2 与 JNJ-78436735 疫苗作为两剂 BNT162b2 疫苗后第三剂在实体器官移植受者中应用的单盲、随机、对照试验的初步研究。
Transpl Int. 2023 Apr 5;36:10938. doi: 10.3389/ti.2023.10938. eCollection 2023.
8
"Saving lives with nirmatrelvir/ritonavir one transplant patient at a time".“一次拯救一名移植患者的生命：尼马曲韦/利托那韦”。
Transpl Infect Dis. 2023 Apr;25(2):e14037. doi: 10.1111/tid.14037. Epub 2023 Feb 27.
9
Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients.体液和细胞免疫与肾移植受者 COVID-19 保护的相关性。
Am J Transplant. 2023 May;23(5):649-658. doi: 10.1016/j.ajt.2023.02.015. Epub 2023 Feb 10.
10
COVID-19 mortality may be reduced among fully vaccinated solid organ transplant recipients.COVID-19 死亡率可能会降低在完全接种疫苗的实体器官移植受者中。
PLoS One. 2022 Dec 21;17(12):e0279222. doi: 10.1371/journal.pone.0279222. eCollection 2022.